Search
toxic shock syndrome
Etiology:
1) Staphylococcus aureus
a) epidemic of cases in menstruating women in early 1980s due to use of 'super-abdorbent' tampons
b) post operative patients, esp ENT cases with nasal packs
c) abscesses, gauze-packed wounds
d) skin ulcers, burns, catheters, injection drug use [1]
2) group A beta-hemolytic Streptococci
- associated with necrotizing fasciitis
Epidemiology:
1) young adults (age 15-34) most commonly affected
2) women comprise 85% of cases
Pathology:
1) Staphylococcus aureus strains that produce:
a) toxic shock exotoxin TSST-1 (20% of S aureus strains), or
b) enterotoxins B or C
2) Streptococcal form of toxic shock syndrome (group A)
a) pyrogenic exotoxin A
b) certain M types
Clinical manifestations:
1) fever > 38.9 C (102.2 F, 39.8 C)
2) hypotension, < 90 mm Hg systolic
3) skin manifestations
a) localized or diffuse erythema 'sunburn rash' macular rash followed by peripheral desquamation in 5-14 days
b) palms & soles affected [1]
c) affected skin has a rough 'sandpaper' texture
4) see Diagnostic criteria
Diagnostic criteria: (CDC)
1) Staphylococcal toxic shock syndrome
a) fever (T > 102 F, 39.8 C)
b) hypotension
- systolic BP < 90 mm Hg
- orthostatic fall in diastolic BP > 14 mm Hg
- symptoms of orthostatic hypotension
c) rash - diffuse macular erythroderma, especially palms & soles [1]
d) desquamation
- occurs 1-2 weeks after onset of symptoms
- especially on palms & soles
e) involvement of 3 or more of the following organ systems
- GI: nausea, vomiting, diarrhea
- muscular: severe myalgias or serum creatine kinase (CK) > 5-fold upper limit of normal
- mucous membranes: hyperemia of vagina, pharynx, conjunctiva
- often best seen in conjunctiva
- renal: creatinine or BUN > 2-fold upper limit of normal or urinalysis with > 5 WBC/hpf
- hepatic: serum transaminases or serum bilirubin > 2-fold upper limit of normal
- hematologic: platelet count < 100,000/mm3
- CNS: altered mental status while afebrile (non-focal exam)
f) negative results on the following tests (if performed)
a) blood, throat & CSF cultures (blood culture may be positive for Staphylococcus aureus)
b) negative serology for Rocky Mountain spotted fever, Leptospirosis or rubeola (measles)
c) CSF cultures
- may grow Staphyloccus aureus
- negative for other organisms
2) Streptococcal toxic shock syndrome
a) isolation of group-A beta-hemolytic Streptococci from a normally sterile site (definite case)
b) isolation of group-A beta-hemolytic Streptococci from a non-sterile site (probable case)
c) hypotension, systolic BP < 90 mm Hg
c) 2 or more of the following
- acute renal failure
- elevated serum transaminases
- erythematous macular rash with soft tissue necrosis
- necrotizing fasciitis
- coagulopathy: thrombocytopenia, DIC
- pulmonary: ARDS
Differential diagnosis:
- Staphylococcal scalded skin syndrome
Management:
1) fluid resuscitation
a) may need massive volumes
b) 10-20 L IV fluids
2) albumin replacement
3) vasopressor support to maintain blood pressure
- norepinephrine drip as needed
4) identify & remove source of infection & toxin
- tampon, nasal packing, abscess
- surgical debridement often needed [1]
5) contact isolation until completion of 24 hours of antibiotic therapy
6) empiric broad spectrum antibiotics until organism is identified [1]
- vancomycin or linezolid + meropenem + clindamycin
- meropenem for gram-negative coverage
- clindamycin for anaerobe & Streptococcal coverage
7) anti-Staphylococcus antibiotics do not alter the course of the disease, but do reduce recurrence rate
a) nafcillin & clindamycin
b) vancomycin or linezolid + clindamycin for MRSA
8) Streptococcal toxic shock syndrome
- penicillin & clindamycin [1]
9) no role for corticosteroids or immune globulin [1]
Prognosis:
1) overall mortality 2-5% (higher in non-menstrual cases)
2) recurrence rate of 30% - recurrent episodes less severe
General
bacterial infection
skin disease (dermatologic disorder, dermatopathy, dermatosis)
References
- Medical Knowledge Self Assessment Program (MKSAP) 14, 15, 16,
17, 18, 19. American College of Physicians, Philadelphia 2006, 2009,
2012, 2015, 2018, 2021
- Medical Knowledge Self Assessment Program (MKSAP) 19
Board Basics. An Enhancement to MKSAP19.
American College of Physicians, Philadelphia 2022
- Harrison's Principles of Internal Medicine, 14th ed.
Fauci et al (eds), McGraw-Hill Inc. NY, 1998, pg 93